Korelasi Kadar Serum Estradiol Dengan Klasifikasi Risiko Osteoporosis Osta (Osteoporosis Self Assessment Tools For Asian) Pada Wanita Menopause

DAFTAR PUSTAKA

1.

Febrina D, Lasmini PS. 2006. Gambaran Densitometry Tulang
Belakang dan Femur di IDT RSUP Dr M Djamil Padang . Universitas
Andalas.

2.

Rachman

IA.

2011.

Osteoporosis.

Available

from:


http://www.medicastore.com/osteoporosis/artikel_utama/22/Tanya_ja
wab_dengan_dokter_ahli_osteoporosis

3.

MenKes R.I. (2008) Keputusan Menteri Kesehatan Republik
Indonesia

nomor

1142/Menkes/SK/XII/2008

tentang

Pedoman

Pengendalian Osteoporosis

4.


Sihombing HC. 2009. Gambaran Kasus Menopause Osteoporosis di
Makmal Terpadu Imunoendokrinologi FK UI. Universitas Indonesia.

5.

Pratiwi R. 2014. Faktor – Faktor Yang Berhubungan Dengan
Kejadian Osteoporosis di Puskesmas Pondok Betung. Universitas
Islam Negeri Syarif Hidayatullah Jakarta.

6.

Beg M, Akhtar N, Alam MF, Rizvi I, et al. Vitamin D status and Serum
Osteocalcin Levels in Post-Menopausal Osteoporosis : Effect of
Bisphosphonate Therapy. JIACM 2014 ; 15 (3-4): 172-6.

7.

Sarmidi S, Setiyohadi B, Anggoro S. Vitamin D Status and
Hyperparathyroidism in Postmenopausal Osteoporotic Patient In

Cipto Mangunkusumo Hospital Jakarta. Indones J Intern Med. 2008.

Universitas Sumatera Utara

8.

Harahap, E.E.S., 2014. Hubungan Kadar Estradiol Serum Dengan
Densitas Tulang pada Wanita Menopause. Universitas Sumatera
Utara.

9.

Speroff L, Osteoporosis and Menopause and Postmenopausal
Hormon Therapy. In Clinical Gynecologic Endocrinology and
Infertility, 8th.ed, Williams & Wilkins, USA, 2011, 583-650 Speroff L,
Osteoporosis

and

Menopause


and

Postmenopausal

Hormon

Therapy. In Clinical Gynecologic Endocrinology and Infertility, 8th.ed,
Williams & Wilkins, USA, 2011, 583-650.

10. Hurd,W.W., Menopause In : Berek JS (ed) Novak’s Gynekology.
Twelfth Edition The william and Wilkins Company,Baltimore, 1996;
29: 981-1011.

11. Kawiyana, I.K.S., 2009, Osteoporosis-Patogenesis, Diagnosis, dan
Penanganan Terkini. J Peny Dalam.10;2: 157-69.

12. Cook,R.B., Collins,D., Tucker,J., Zioupos,P., Comparison of
questionnaire and quantitative ultrasound techniques as skrining
tools for DXA. International Osteoporosis Foundation and National

Osteoporosis Foundation. (2005) 16: 1565–1575.

13. Chaovisitsaree S, Namwongprom SA. Nuntana, M. et al. Comparison
of Osteoporosis Self Assessment Tool for Asian (OSTA) and
Standard Assessment in Menopause Clinic, Chiang Mai. J Med
Assoc Thai 2007; 90 (3): 420-5.

Universitas Sumatera Utara

14. Chaiyakunaprok, N.

Laowakul, A.

Karnchanarat. Community

Pharmacy–Based Implementation and Evaluation of an Osteoporosis
Self- Assessment Tool for

Asians S. journal of the American


Pharmacist Association. 2006;46: 391-396.

15. Bei Tao, Jian-min Liu, Xiao-ying Li, et al. An assessment of the use
of quantitative ultrasound and the Osteoporosis Self-Assessment
Tool for Asians in

determining the risk of nonvertebral fracture in

postmenopausal Chinese women .

Bone Minner Metab Journal.

2008(26):60-65.

16. Iswayuni N. 2011. Pemberian ekstrak Plasenta Meningkatkan
Estradiol dan FSH Serta Mengurangi Gejala Menopause. Universitas
Udayanan Denpasar.

17. Lubis, J.M., 2015. Korelasi Kadar 25-Hydroxyvitamin D dan Kadar
Estradiol Serum Dengan Densitas Tulang Pada Wanita Menopause.

Universitas Sumatera Utara.

18. Baziad A. Menopause dan Andropause. Yayasan Bina Pustaka
Sarwono Prawirohardjo. Juni 2003.

19. Abementhy K, Hillard A, McFall P, Holloway D, Robinson J, et al.
2015. Menopause : Lifestyle and Therapeutic Approaches. Royal
College of Nursing.

20. Speroff L, et al. Menopause and the perimenopausal transition in:
ClinicalGynecologic Endocrinology and Infertility; 7th ed. Lippincott
Williams and Wilkins; Philadelphia 2005:621-73.

Universitas Sumatera Utara

21. Pangestu, W.M., 2014. Korelasi C-Telopeptide Plasma dengan
Klasifikasi

Resiko


Osteoporosis

OSTA

(Osteoporosis

Self

Assessment Tools For Asian) pada Wanita Pasca Menopause.
Universitas Sam Ratulangi Manado.

22. Siregar, M.F.G.,. Salivary cortisol level as psychological disorders
marker that assessed according to menopause rating scale on
perimenopausal women in indonesia-medan. Giorn. It. Ost. Gin. Vol
XXXVIII-n.1.2016;197-200.

23. Siregar, M.F.G., et.all,. The Difference of Catalase Enzyme Level
Between Menopause and Reproductive Women. Giorn. It. Ost. Gin.
Vol XXXVII-n.6. 2015; 278-282.


24. Nagpal,N.K., 2009. Water Quality Guidelines for Pharmaceuticallyactive Compounds (PhACs) : 17β-ethinylestradiol (EE2). Ministry of
Environment Province of British Columbia.

25. Nasution, H.H.D., 2013. Perbandingan Keluhan Menopause pada
Paramedis Masa Perimenopause dan Pascamenopause dengan
Menggunakan Menopause Rating Scale di RSUP Haji Adam Malik
Medan dan RS Jejaring FK USU. Universitas Sumatera Utara.

26. Wardhana,W.,

2012. Faktor – faktor Resiko Osteoporosis pada

Pasien dengan Usia di Atas 50 tahun. Universitas Diponegoro

27. Aprilia, D.A., 2010. Terapi Suluh Hormon Pada Osteoporosis.
Universitas Sumatera Utara.

Universitas Sumatera Utara

28. Viani, H., 2010. Gambaran Pengetahuan, Sikap dan Tindakan

Pencegahan Osteoporosis pada Wanita Usia Subur di Kelurahan Jati
Makmur Kecamatan Binjai Utara Tahun 2010. Universitas Sumatera
Utara.

29. Manolagas, S.C., Jilka, R.L., 1995, Bone marrow cytokines and bone
remodelling

emerging

insights

into

the

pathophysiology

of

osteoporosis. N Eng J Med ;332(5):305-10


30. Ross, P.D., Osteoporosis frequency, consequences and risk factor:
Arch. Internal Med; 1996; 156(13):1399-14

31. Percival M. Bone Health and Osteoporosis. Advanced Nutrition
Publications. 1999; Vol.5 no.4:1-6

32. Mahmudati N. Peran Estrogen / Fitoestrogen pada Metabolisme
Tulang Usia Menopause. Universitas Muhammadiyah Malang

33. Setiyohadi B. 2006. Osteoporosis dalam Sudoyo. A.W., Setyohadi,
B., Alwi, I., Simadibrata, M., Setiati, S, (eds) Buku Ajar Ilmu Penyakit
Dalam. Edisi IV. Pusat Penerbitan Departemen Ilmu Penyakit Dalam
FKUI. Jakarta; 1269-83

34. Nakchbandi IA, Van Ser Merwe, S.W., 2009. Current understanding
of osteoporosis associated with liver disease. Gastroenterology and
Hepatology, vol 6:660-70

35. Osteoporosis Prevention, Diagnosis and Therapy. NIH Consensus
Statement 2000 March 27-29;17(1):1-45.

Universitas Sumatera Utara

36. Permana H, 2012. Patogenesis dan Metabolisme Osteoporosis pada
Manula. Universitas Padjajaran Bandung

37. Badarudeen

a,

2015,

osteoporosis,

available

form:

http://www.slideshare.net/AseemBadarudeen/osteoporosis-ppt49486060 diunduh tanggal 28 february 2016

38. NAMS Continuing Medical Education Activity. Management Of
Osteoporosis in Postmenopausal Women: 2010 Position Statement
of The North American Menopause Society. Vol 17 No.1:23-39

39. Setiyohadi B, et al. Summary of the Indonesian Guidelines for
Diagnosis and Management of Osteoporosis. Journal of the ASEAN
Federation of Endocrine Societies, 2012:Vol 27(2):147-150.

40. Suzuki T. Risk Faktor for Osteoporosis in Asia. J Bone Miner metab.
2001:19:133-141.

41. Mundi JS, Cabalero FJC, Abadia HC, and Ibnes JJM. Bone massa
density

and

serum

levels

of

soluble

TNF,

estradiol

and

osteoprotegerin in postmenopause women. Journal of clinical
endocrinology and metabolism. 2009; Vol. 94 No. 12:4844-50.

42. Lerner UH. Bone remodelling in post-menopausal osteoporosis. J
Den Res 85,2006:584-595.

43. Clarke BL, Khosia S. Physiology of Bone Loss. Radiol Clin North Am.
2010; 48(3): 483-495

44. Savica V, Bellinghieri G, Monardo P, Muraca U, Santoro D. An
Update on Calcium Metabolism alterations and Cardiovascular risk in

Universitas Sumatera Utara

patients with chronic kidney disease: questions, myths and facts.
Journal of Nephrology 2013; Vol 26(3): 456-464.

45. Koh LK, Sedrine WB, Torralba TP, et al. Osteoporosis SelfAssessment Tool for Asians (OSTA) Research Group. A simple tool
to identify Asian women at increased risk ofosteoporosis. Osteoporos
Int. 2001(12):699–705.

46. Muslim DAJ, Mohd EF, Sallehudin AY, et al. Performance of
Osteoporosis Self-assessment Tool for Asian (OSTA) for Primary
Osteoporosis in Postmenopausal Malay Women.

Malaysian

Orthopaedics Journal. 2012; vol 6 (1) : 35-39

47. Patel SM, Jadhav PR, Vieira A. Association of OSTA index with bone
mineral density (BMD) and its comparison with calcaneal quantitative
ultrasound for the prediction of low BMD in peri-menopausal Indian
women. International Journal of Research in Medical Sciences 2014
nov ; 2(4): 1495-1499

48. Li-Yu JT, Liamado LJQ, Toralba TP. Validation of OSTA among
Filipinos. Osteoporosis Int 2005 ; 16 : 1789 – 1793.

49. Anonym. Osteoporosis and You. Available from : http://www.msdsingapore.com/Assets/Osteoporosis.pdf. Acces March 1,2016

50. Anonym. 2012. Clinical Guidance on Management of Osteoporosis.
Malaysian Osteoporosis Society.

Universitas Sumatera Utara

51. Anonym. Treatment of osteoporosis. Chapter 4. Available from :
http://www.topf.or.th/ckfinder/userfiles/files/topf_pdf/cpg_en2.pdf.
Acces February 27,2016.

52. Reginster, J.Y., Osteoporosis Self-assesssment Tool (OST)[& OSTA
for

Asians].Available

fosavance.ae/secure/resources/tools/media/

from:
OSTA.ppt.

Acces

December 10,2016.

53. Koh WP, Lee HP. Postmenopausal Gynecological Cancers : the
Singapore perspective and its general applicability. Menopausal
Medician 2007 May: Vol 15(1) : 1-14

54. Park HM, Sedrine WB, Reginster JY, Ross PD. Korean experience
with the OSTA Risk Index for Osteoporosis. Journal of Clinical
Densitometry 2003; Vol 6(3) : 247-250.

55. Pratomo, D.S., Astuti. E.Z., 2015, Analisis regresi dan korelasi antara
pengunjung dan pembeli terhadap pembelian nominal di Semarang.
Available from : http://eprints.dinus.ac.id/16877/1/jurnal_15951.pdf.
Diunduh tanggal 14 Desember 2016.

Universitas Sumatera Utara